Pentedrone

1. 2026-10-02issueIssued info_card
2. 2026-10-02srcChemical analysis of two new designer drugs: buphedrone and pentedrone
3. 2026-10-02srcAnalytical Challenges in Detecting NPS in Anti-Doping: A Proof-of-Concept Involving Pentedrone Metabolite
4. 2026-10-02srcThe utility of silica hydride-based stationary phases for ultra high performance liquid chromatography separation of synthetic cathinone positional isomers
5. 2026-10-02srcNeurotoxicology of Synthetic Cathinone Analogs
6. 2026-10-02srcIn vitro cytochrome P450 inhibition potential of methylenedioxy-derived designer drugs studied with a two-cocktail approach
7. 2026-10-02srcScheduling synthetic cathinone substances under the Controlled Substances Act
8. 2026-10-02srcHyperthermia and multiorgan failure after abuse of 'bath salts' containing 3,4-methylenedioxypyrovalerone
9. 2026-10-02srcPrevalence of New Psychoactive Substances (NPS) and conventional drugs of abuse in high risk populations from Paris (France): A cross sectional study by hair testing (2012-2017)
10. 2026-10-02srcWastewater-based epidemiology to assess the occurrence of new psychoactive substances and alcohol consumption in Slovakia
11. 2026-10-02srcFatal intoxication involving 4-methylpentedrone (4-MPD) in a context of chemsex
12. 2026-10-02srcSynthetic cathinones in drug-facilitated sexual assault: A case report involving N-ethylpentedrone
13. 2026-10-02srcBinding studies of synthetic cathinones to human serum albumin by high-performance affinity chromatography
14. 2026-10-02srcThe role of syringe residue analysis in identifying substances consumed in sexualized drug use practices
15. 2026-10-02srcNew psychoactive versus conventional stimulants - a ten-year review of casework in Hungary.
16. 2026-10-02srcMonoamine transporter and receptor interaction profiles of a new series of designer cathinones
17. 2026-10-02srcRole of amino terminal substitutions in the pharmacological, rewarding and psychostimulant profiles of novel synthetic cathinones.
18. 2026-10-02srcLocomotor stimulant and drug discrimination effects of five synthetic cathinones in rodents
19. 2026-10-02srcEffect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?
20. 2026-10-02srcRepeated administration of N-ethyl-pentedrone induces increased aggression and impairs social exploration after withdrawal in mice
21. 2026-10-02srcS-(+)-Pentedrone and R-(+)-methylone as the most oxidative and cytotoxic enantiomers to dopaminergic SH-SY5Y cells: Role of MRP1 and P-gp in cathinones enantioselectivity
22. 2026-10-02srcDo 2-(Benzoyl)piperidines Represent a Novel Class of hDAT Reuptake Inhibitors?
23. 2026-10-02srcStructure-Activity Relationship of N-Ethyl-Hexedrone Analogues: Role of the alpha-Carbon Side-Chain Length
24. 2026-10-02srcSynthetic Cathinones in Belgium: Two Case Reports with Different Outcomes Observed in the Emergency Room
25. 2026-10-02srcTesting for designer stimulants: metabolic profiles of 16 synthetic cathinones excreted free in human urine.
26. 2026-10-02srcCharacterization of Hepatotoxicity Mechanisms Triggered by Designer Cathinone Drugs
27. 2026-10-02srcAnalysis of the first- and second-generation Raving Dragon Novelty Bath Salts containing methylone and pentedrone
28. 2026-10-02srcDetection of legal highs in the urine of methadone-treated patient by LC-MS
29. 2026-10-02srcStructure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release
30. 2026-10-02srcComparison of locomotor stimulant and drug discrimination effects of four synthetic cathinones to commonly abused psychostimulants
31. 2026-10-02srcEmerging drugs of abuse: current perspectives on substituted cathinones
32. 2026-10-02srcStructure-Activity Relationship of Novel Second-Generation Synthetic Cathinones: Mechanism of Action, Locomotion, Reward, and Immediate-Early Genes
33. 2026-10-02srcGC-MS/MS Determination of N-ethyl Pentedrone and N-ethyl Hexedrone in Oral Fluid and Sweat after Controlled Administration
34. 2026-10-02srcAcute Pharmacological Effects of Two Synthetic Cathinones in Humans: N-Ethylhexedrone and N-Ethyl-nor-pentedrone
35. 2026-10-02srcSchedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I. Final order.
36. 2026-10-02srcSchedules of Controlled Substances: Extension of Temporary Placement of 10 Synthetic Cathinones in Schedule I. Final order.
37. 2026-10-02srcPatterns of Use, Acute Subjective Experiences, and Motivations for Using Synthetic Cathinones in Recreational Users
38. 2026-10-02srcSchedules of Controlled Substances: Placement of 10 Synthetic Cathinones Into Schedule I. Final rule.
39. 2026-10-02srcPentedrone - Chemical and physical properties, CAS 879722-57-3
40. 2026-10-02srcPentedrone - UNODC Substance Details
41. 2026-10-02srcPentedrone - HandWiki (Chemistry:Pentedrone)
42. 2026-10-02srcUK Misuse of Drugs Act 1971 (Amendment) Order 2010 - S.I. 2010/1207
43. 2026-10-02publicationPublication — publishagent-psx
44. 2026-10-02revisionr1.a1
45. 2026-10-02rulingRuling — psx:substance/pentedrone/proposal/article_section_proposals/2c5b8cee-c015-488e-9f5b-91255f865ef9founder
46. 2026-10-02rulingRuling — psx:substance/pentedrone/proposal/article_section_proposals/c12d1cdf-6645-4685-94c7-c9997c1d0666founder
47. 2026-09-04issueIssued emergency
48. 2026-09-04issueIssued info_card
49. 2026-09-04issueIssued notice
50. 2026-06-04proposal40 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
51. 2026-06-04publicationPublication — backfill
52. 2026-04-26revisionRevision 1
53. 2026-04-26absenceSearched ClinicalTrials.gov for "pentedrone" — no results
54. 2026-04-26genGeneration — pipeline-v5 · with 2 morepipeline-v5
55. 2026-04-26rungeneration run

The same entries, as forms: six forms.